BCAS2 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

	Compound	Confidence	Supporting neighbours

Clinical trials — most relevant to BCAS2 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia	nan	NOT_YET_RECRUITING
SRSF2 Gene Mutation in Patients With t-MDS/AML	nan	COMPLETED
Patient's Derived Organoids for Drug Screening in Glioblastoma	nan	NOT_YET_RECRUITING
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC	nan	UNKNOWN
Genetic Variation in TRAF3IP2 (rs13190932)	nan	RECRUITING
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF)	nan	COMPLETED
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients	nan	UNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population	nan	COMPLETED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors	nan	COMPLETED
Autophagy in Systemic Lupus Erythematosus	nan	UNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis	nan	COMPLETED
Mechanisms of Cell Death in Spinal Muscular Atrophy	nan	COMPLETED
Biocollection in MyeloDysplastic Syndrome (P-MDS)	nan	RECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic	nan	COMPLETED
Clinical Study of Spinal Muscular Atrophy	nan	COMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus	nan	COMPLETED
Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow Failure Syndromes	nan	RECRUITING
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases	nan	UNKNOWN
Analysis of Post-Translational Modifications of a Critical Protein Implicated in Amyotrophic Lateral Sclerosis	nan	COMPLETED
Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia	nan	RECRUITING
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact	nan	UNKNOWN
Muscle Tissue Bank for Muscular Dystrophy	nan	COMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy	nan	UNKNOWN
Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study	nan	UNKNOWN
CDH1 Germline Mutations in Lobular Breast Cancer	nan	COMPLETED
Study of Constitutional Platelet Disease	nan	UNKNOWN
Family Study of Melanoma in Italy	nan	COMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress	nan	WITHDRAWN
Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases	nan	RECRUITING
RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a BCAS2 binder may also engage these)

Protein	Name	Similarity
Q5RAX7	—	1.000	Q5RAX7 →
Q9D287	—	1.000	Q9D287 →
Q6PBE2	—	0.998	Q6PBE2 →
Q5RKQ0	—	0.991	Q5RKQ0 →
Q7ZXA8	—	0.985	Q7ZXA8 →
Q8BYR5	—	0.985	Q8BYR5 →
A1A5Q4	—	0.984	A1A5Q4 →
Q96JB5	—	0.984	Q96JB5 →
F4HPA7	—	0.984	F4HPA7 →
Q96G25	—	0.983	Q96G25 →
Q32KY1	—	0.983	Q32KY1 →
Q28DG8	—	0.983	Q28DG8 →
Q5ZHV2	—	0.983	Q5ZHV2 →
Q5REX6	—	0.982	Q5REX6 →
Q80TJ1	—	0.982	Q80TJ1 →
O57595	—	0.982	O57595 →
Q2TBU8	—	0.982	Q2TBU8 →
Q2TBK4	—	0.982	Q2TBK4 →
Q5RFD3	—	0.982	Q5RFD3 →
Q9NWB7	—	0.982	Q9NWB7 →
Q6GLR7	—	0.982	Q6GLR7 →
Q6DFL5	—	0.982	Q6DFL5 →
Q29RL1	—	0.981	Q29RL1 →
Q5FW42	—	0.981	Q5FW42 →
Q6DGZ3	—	0.981	Q6DGZ3 →
Q6DKG0	—	0.981	Q6DKG0 →
B1AY13	—	0.981	B1AY13 →
Q9R0A8	—	0.981	Q9R0A8 →
Q62141	—	0.981	Q62141 →
Q6GPR9	—	0.981	Q6GPR9 →